Picture of Fresenius SE & Co KGaA logo

FRE Fresenius SE & Co KGaA Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Fresenius SE & Co KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,8232,8192,117238867
Depreciation
Deferred Taxes
Non-Cash Items-6042-1162,3188
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Changes in Working Capital1,028-534-661403303
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6,5495,0784,1984,4202,415
Capital Expenditures-2,406-2,047-1,917-1,134-923
Purchase of Fixed Assets
Other Investing Cash Flow Items-605-770-690-2,053413
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-3,011-2,817-2,607-3,187-510
Financing Cash Flow Items-980-60145-1,589-62
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,117-1,452-1,604-1,377-2,183
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash183927-15-187-280